The prognosis of patients with aggressive systemic mastocytosis (ASM) remains ominous. In the absence of curative options, therapy has relied upon cytoreductive agents such as interferon-a, corticos-teroids, and cladribine. Daclizumab is a monoclonal humanized antibody that targets CD25, the ...
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Aggressive systemic mastocytosis (ASM) is a clonal mast cell disease characterized by progressive growth of neoplastic cells in diverse organs leading to o... P Valent,C Akin,WR...
Germ cell tumor - foreshadow of systemic mastocytosis: report of a rare case We report a case of aggressive systemic mastocytosis in a 3-year-old girl, who had undergone treatment for ovarian germ cell tumor during the previous 8 mo... V Munikoty,R Jain,S Sreedharanunni,... - 《Ped...
systemic mastocytosisManagement of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases....
Aggressive systemic mastocytosis mimicking lymphoma: description of an unusual presentation and review of the literature on current management strategies.Aggressive systemic mastocytosis mimicking lymphoma: description of an unusual presentation and review of the literature on current management strategies.mastoc...
Quantifying Diagnostic Delays in Patients with Indolent and Aggressive Systemic Mastocytosis doi:10.1016/j.jaci.2023.11.720Journal of Allergy and Clinical ImmunologyHunter MillsChristoper Yuen PharmDCecilia Arana-YiVivek Rudrapatna
(A-B): Normocellular bone marrow trephine biopsy with small foci of paratrabecular mast cell infiltration (arrows), some with spindle cell morphology [haematotoxylin and eosin stain, 脳20 (A) and 脳100 (B)]. In a multicentre phase II study, 57% of patients with systemic mastocytosis ...
Aggressive Systemic Mastocytosis: Types, Symptoms, Diagnosis and Treatmentdoi:10.35248/2684-1266.21.7.131Krupa PalanLongdom Publishing S.L
Aggressive systemic mastocytosis (ASM) is a rare but well-defined subtype of systemic mastocytosis (SM). The diagnosis of ASM is based on distinct morphological findings and the presence of clinical characteristics as consequence of SM-induced organ damage. Clinical findings of organ damage caused ...
Treatment of aggressive systemic mastocytosis with daclizumab. Leuk Lymphoma. 2010;51(3):540-542.A. Quintas-Cardama, H.M. Amin, H. Kantarjian, S. Verstovsek, Treatment of aggressive systemic mastocytosis with daclizumab, Leuk. Lymphoma 51 (March (3)) (2010) 540-542....